Skip to main content

Sanofi

SNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001121404

No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 691 institutions reported holding it in 13F filings for Q3 2026, worth $7.15B in total; Maverick Capital is the only superinvestor holding it.

Other share classesSNYNF

Key figures

Market capADS ratio not in SEC data
–
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, −11 vs. previous quarter
692
13F valueReported value at the end of Q3 2026
$7.15B
Superinvestors holdingAt the end of Q3 2026
1

Price chart

From SEC filings, in EUR.

Revenue, FY2025
EUR 43.6B
+6.2% year over year
Net income, FY2025
EUR 7.85B
+39.7% year over year
Free cash flow, FY2025
–
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
12.3M
Shares sold short
Change
+679.6K
+5.9% vs. previous
Days to cover
2.85
At average daily volume

Superinvestors holding SNY, Q3 2026

Go to the superinvestors tab

1 superinvestor reports holding Sanofi on Form 13F. Percentages are the stock's share of each portfolio.

Maverick Capital

Lee Ainslie

<0.1%

Sanofi's share of the portfolio

Shares
102,208
Value
$4.21M

Latest insider trades

See all insider trades

Open-market purchases and sales by Sanofi insiders from Form 4, newest first.

No open-market purchases or sales by Sanofi insiders are on file.

Top 10 13F holders, Q3 2026

See all 692 holders

The largest institutional positions in Sanofi at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding SNY in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Dodge & Cox15,668,529$646.0M0.35%−12,419,745−44.2%Reduced
Morgan Stanley14,900,060$614.3M0.03%+4,197,533+39.2%Added
Fisher Asset Management, LLC9,597,228$395.7M0.11%−1,029,860−9.7%Reduced
Bank of America Corp7,840,212$323.3M0.02%−168,360−2.1%Reduced
JPMorgan Chase & Co7,330,737$298.7M0.02%+757,055+11.5%Added
Invesco Ltd.6,271,955$258.6M0.02%−527,006−7.8%Reduced
Mondrian Investment Partners LTD5,652,139$233.0M5.16%+129,575+2.3%Added
Millennium Management LLC5,596,183$230.7M0.17%+1,868,293+50.1%Added
Federated Hermes, Inc.5,455,928$224.9M0.32%+1,606,126+41.7%Added
Brandes Investment Partners, LP4,306,275$177.5M1.22%+169,858+4.1%Added

Holders of 5% or more of SNY

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sanofi.

Largest holders of SNY from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Amundi13G/A5.70%68.8M shares+0.05 ppfrom 5.65%Feb 16, 202114 filingsOct 26, 2026SEC

7 members of Congress reported 12 trades in Sanofi since 2020. Newest filings:

  1. Alan Armstrong

    Senate · OK · Jul 21, 2026

    Buy$15K-$50K

  2. Lisa C. McClain

    House · MI · Oct 22, 2025

    Sell$1K-$15K

  3. Lisa C. McClain

    House · MI · Sep 12, 2025

    Buy$1K-$15K

  4. Lisa C. McClain

    House · MI · Aug 13, 2025

    Buy$1K-$15K

  5. Lisa C. McClain

    House · MI · Aug 13, 2025

    Sell$1K-$15K